Author:
Darrow David H.,Greene Arin K.,Mancini Anthony J.,Nopper Amy J.,Antaya Richard J.,Cohen Bernard,Drolet Beth A.,Fay Aaron,Fishman Steven J.,Friedlander Sheila F.,Ghali Fred E.,Horii Kimberly A.,Patel Manish N.,Metry Denise W.,North Paula E.,O Teresa M.,Perkins Jonathan A.,Smith Michael L.,Treadwell Patricia A.,Waner Milton,Yan Albert C.,Bruckner Anna L.,Horii Kim,Silverberg Nanette B.,Wright Teresa S.,Bower Charles,Baldassari Christina,Digoy German Paul,Hotaling Andrew,Ishman Stacey,McClay John,Preciado Diego,Rosbe Kristina,Schoem Scott,Simons Jeffrey,Sobol Steven,Walner David,Taub Peter J.,Baker Stephen B.,Greene Arin K.,King Timothy W.,Mackay Donald R.,Mount Delora L.,Steinberg Jordon Philip,Urata Mark M.,
Abstract
Infantile hemangiomas (IHs) are the most common tumors of childhood. Unlike other tumors, they have the unique ability to involute after proliferation, often leading primary care providers to assume they will resolve without intervention or consequence. Unfortunately, a subset of IHs rapidly develop complications, resulting in pain, functional impairment, or permanent disfigurement. As a result, the primary clinician has the task of determining which lesions require early consultation with a specialist. Although several recent reviews have been published, this clinical report is the first based on input from individuals representing the many specialties involved in the treatment of IH. Its purpose is to update the pediatric community regarding recent discoveries in IH pathogenesis, treatment, and clinical associations and to provide a basis for clinical decision-making in the management of IH.
Publisher
American Academy of Pediatrics (AAP)
Subject
Pediatrics, Perinatology and Child Health